MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)

Meeting: MDS Virtual Congress 2020

Abstract Number: 715

Keywords: Cognitive dysfunction, Hallucinations, Non-motor Scales

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD.

Background: There is no standard criteria for the diagnosis of APD and local practices can vary between countries, making it difficult to anticipate treatment outcomes as Parkinson’s disease (PD) progresses. OBSERVE-PD examined disease characteristics in patients with APD.

Method: OBSERVE-PD was an observational, cross-sectional, multi-country study. The study included a total of 2615 PD patients from 128 movement disorder centers in 18 countries. Investigator assessment was used to categorize patients as APD or non-APD. Non-motor symptoms were assessed using the Non-motor Symptom Scale (NMSS) during a single study visit. Descriptive statistics were used to analyze results.

Results: Mean total NMSS score varied by country, but was consistently higher for APD patients than non-APD patients, reflecting an increased non-motor symptom burden in APD patients (total NMSS score intercountry range, APD: 32.4 to 87.8; non-APD: 14.7 to 53.2) [table1]. More patients with “mild” NMSS scores had non-APD than APD (51.7% to 92.9% had non-APD), except in 4 countries (50.0% to 68.8% had APD) [table2]. Across countries, with the exception of Ireland, the majority of patients with “very severe” NMSS scores were categorized as APD (54.5% to 100% had APD) [table2]. Across all NMSS score domains (cardiovascular including falls; sleep/fatigue; mood/cognition; perceptual problems and hallucinations; attention and memory; gastrointestinal; urinary; sexual function; and miscellaneous), patients with APD generally had higher mean scores than did those with non-APD.

Conclusion: These findings confirm that overall non-motor symptom burden was worse for patients categorized as APD than those who were non-APD. Patients with APD had higher mean NMSS scores, and this trend was generally consistent across individual NMSS domains. More patients with “very severe” NMSS total scores had APD than non-APD. The findings were consistent over the participating 18 countries.

Table1

Table2

To cite this abstract in AMA style:

A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek. Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/non-motor-symptoms-in-advanced-vs-non-advanced-parkinsons-disease-a-subgroup-analysis-of-the-observe-pd-observational-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-motor-symptoms-in-advanced-vs-non-advanced-parkinsons-disease-a-subgroup-analysis-of-the-observe-pd-observational-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley